Advancing health one disease at a time

Therapeutic Treatment Development

Contact Us

Therapeutic Development & Testing

Cardiology Infectious Diseases Neurology Oncology & Immunoncology Rheumatology

No matter what therapeutic area or disease indication you’re developing for, you can tap into our extensive experience and get your pharmaceutical drug or medical device to the people who need it. 

We can help you test your therapeutic treatment throughout its entire lifecycle of development. 

Scientific Posters

Immuno-oncology Clinical Trials by the Numbers
Assessment of Immunogenicity in SARS-CoV-2 Naïve and Convalescent Subjects Following COVID-19 Vaccination
Sep. 26, 2022
Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Rats from 104-Week Carcinogenicity Studies
Sep. 13, 2022
Several Cases of Spontaneous Type 2 Diabetes Mellitus in Stock Cynomolgus Monkeys
Sep. 13, 2022
Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Mice from Carcinogenicity Studies
Sep. 13, 2022
Comprehensive analysis of the association between RAS mutation and immune checkpoint marker expression
Sep. 12, 2022
A Mechanistic Insight into the Lung-Derived Inflammatory Response Following In Vitro Exposure to Cigarette Smoke and Next-Generation Nicotine Delivery Products
Jul. 03, 2022
Development of an In Vitro Assay for Assessment of IL-2 Independent CAR T Proliferation
May 16, 2022
In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA
May 16, 2022
Comprehensibility and Usability of an Electronic COVID-19 Daily Symptom Diary
May 15, 2022

Let's start a conversation

Contact Us
Labcorp Drug Development logo

Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.

Navigation
Scroll to top